According to previous studies, IGF2BP3 is highly expressed in numerous cancer tissues, such as esophageal cancer, lung cancer, prostate cancer, gastric cancer, and colorectal malignancies (Shantha Kumara et al., 2015; Zhang et al., 2017). This evidence concerns the gene IGF2BP3 and lung carcinoma.